These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

111 related items for PubMed ID: 20570519

  • 1. Comment on "Non-surgical treatment of hormone-secreting pituitary tumors".
    Dobson M, Del Porto L, Maartens NF.
    J Clin Neurosci; 2010 Sep; 17(9):1220-1. PubMed ID: 20570519
    [No Abstract] [Full Text] [Related]

  • 2. Treatment of pituitary tumors: somatostatin.
    Tichomirowa MA, Daly AF, Beckers A.
    Endocrine; 2005 Oct; 28(1):93-100. PubMed ID: 16311415
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Authors' Reply to "Pituitary Atypical Adenoma or Carcinoma Sensitive to Temozolomide Combined with Radiation Therapy: A Case Report of Early Identification and Management".
    Curtò L, Trimarchi F.
    Turk Neurosurg; 2015 Oct; 25(4):679-80. PubMed ID: 26242353
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Medical approach to pituitary tumors.
    Neggers SJ, van der Lely AJ.
    Handb Clin Neurol; 2014 Oct; 124():303-16. PubMed ID: 25248595
    [Abstract] [Full Text] [Related]

  • 10. Temozolomide-induced shrinkage of a pituitary carcinoma causing Cushing's disease--report of a case and literature review.
    Curtò L, Torre ML, Ferraù F, Pitini V, Altavilla G, Granata F, Longo M, Hofland LJ, Trimarchi F, Cannavò S.
    ScientificWorldJournal; 2010 Nov 04; 10():2132-8. PubMed ID: 21057727
    [Abstract] [Full Text] [Related]

  • 11. [Somatostatin analogs in the clinical management of pituitary neoplasms].
    Colao A, Dorato M, Pulcrano M, Rossi FW, Auriemma RS, Lombardi G, Lastoria S.
    Minerva Endocrinol; 2001 Sep 04; 26(3):181-91. PubMed ID: 11753242
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Long term treatment with the somatostatin analog SMS 201-995 in a patient with a thyrotropin- and growth hormone-secreting pituitary adenoma.
    Wémeau JL, Dewailly D, Leroy R, D'Herbomez M, Mazzuca M, Decoulx M, Jaquet P.
    J Clin Endocrinol Metab; 1988 Mar 04; 66(3):636-9. PubMed ID: 2895119
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Pre-clinical and clinical experiences with novel somatostatin ligands: advantages, disadvantages and new prospects.
    Hofland LJ, van der Hoek J, Feelders R, van der Lely AJ, de Herder W, Lamberts SW.
    J Endocrinol Invest; 2005 Mar 04; 28(11 Suppl International):36-42. PubMed ID: 16625843
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.